Kamel Boumali

Kamel Boumali has extensive work experience in the field of business development, primarily in the pharmaceutical and clinical research industries. Kamel has held various senior roles in prominent organizations, including Worldwide Clinical Trials, ERGOMED, IQVIA, Innovenn, Oncodesign, GenericsWeb, Novartis, Winner, and Ethypharm.

In these roles, Kamel has demonstrated expertise in driving business growth and development, building professional relationships with clients, and contributing to the success of drug development and clinical trials. Kamel has gained a strong understanding of the pharmaceutical industry and its regulatory requirements.

Kamel's experience spans across multiple phases of clinical trials, clinical trial management, post-approval pharmacovigilance, medical information, and orphan drug development. Kamel has also been involved in the launch of generic drugs and provided patent intelligence services.

Throughout their career, Kamel has proven to be a valuable asset in driving sales performance, promoting pharmaceutical products, and establishing organizations as leaders in their respective fields. Kamel has effectively contributed to the success of companies and the advancement of medical treatments.

Overall, Kamel Boumali's work experience showcases their expertise in business development, clinical research, pharmaceuticals, and regulatory compliance. Kamel'scontributions have positively impacted the growth and success of the organizations they have worked with.

Kamel Boumali completed a Post Graduate Degree in Pharmaceutical Engineering from Université Henri Poincaré, Nancy 1 during the years 1998 to 1999. Kamel then pursued a Master's program in Management of Pharmaceutical Industry at Burgundy School of Business - BSB from 2000 to 2001. Kamel'sstudies covered a range of subjects including marketing, project management, business development, financial analysis, accounting, and general corporate policy.